BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6394170)

  • 1. [Relapses and indirect fluorescent antibody level in vivax malaria patients after chloroquine and chloroquine-primaquine treatment].
    Wang K; Liu YL; Zhang PN; Liu JX
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):224-7. PubMed ID: 6394170
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapses of vivax malaria after a conventional course of primaquine and chloroquine: report of 2 cases.
    Charoenlarp P; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1973 Mar; 4(1):135-7. PubMed ID: 4577922
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of treatment schedules for Plasmodium vivax infections in the Solomon Islands.
    Saint-Yves IF
    P N G Med J; 1977 Jun; 20(2):62-5. PubMed ID: 339599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 5 day radical treatment of primaquine in Plasmodium vivax cases at the BHEL industrial complex, Hardwar (U.P.).
    Sinha S; Dua VK; Sharma VP
    Indian J Malariol; 1989 Jun; 26(2):83-6. PubMed ID: 2676618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse pattern of Plasmodium vivax in Kheda district, Gujarat.
    Sharma RC; Gautam AS; Orlov V; Sharma VP
    Indian J Malariol; 1990 Jun; 27(2):95-9. PubMed ID: 2209933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of malaria.
    O'Brien W
    Practitioner; 1975 Oct; 215(1288):487-92. PubMed ID: 1105541
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent-antibody patterns in naturally acquired vivax malaria.
    Fisher GU; Sulzer AJ; Wilson M; Runcik K
    Am J Trop Med Hyg; 1970 Mar; 19(2):209-14. PubMed ID: 4910775
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of 3-day radical treatment of Plasmodium vivax in North Arcot and South Arcot Districts of Tamil Nadu.
    Appavoo NC; Roy RG; Kapali V
    Indian J Malariol; 1984 Jun; 21(1):21-4. PubMed ID: 6399257
    [No Abstract]   [Full Text] [Related]  

  • 12. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S; Nasveld P; Edstein MD
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chloroquine-primaquine therapy against vivax malaria.
    Contacos PG; Collins WE; Chin W; Jeter MH; Briesch PE
    Am J Trop Med Hyg; 1974 Mar; 23(2):310-2. PubMed ID: 4594076
    [No Abstract]   [Full Text] [Related]  

  • 14. Malaria antibody titres as measured by the indirect fluorescent antibody test in relation to parasitaemia and treatment.
    Pillay MR; Frank H; Ponnampalam JT
    Southeast Asian J Trop Med Public Health; 1981 Mar; 12(1):111-3. PubMed ID: 7020094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of vivax malaria.
    Med Lett Drugs Ther; 1968 May; 10(11):44. PubMed ID: 4872214
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloroquine sensitivity of Plasmodium vivax in Thailand.
    Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
    Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical treatment of vivax malaria in Madhya Pradesh, India.
    Singh N; Mishra AK; Sharma VP
    Indian J Malariol; 1990 Mar; 27(1):55-6. PubMed ID: 2200726
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man.
    McCarthy VC; Clyde DF
    Exp Parasitol; 1977 Feb; 41(1):167-71. PubMed ID: 320027
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmodium vivax from Vietnam. Response to chloroquine-primaquine.
    Hiser WH; MacDonald BS; Canfield CJ; Kane JJ
    Am J Trop Med Hyg; 1971 May; 20(3):402-4. PubMed ID: 4932528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.